Home/Pipeline/CLAAS AcuFORM System

CLAAS AcuFORM System

Stroke prevention in patients with non-valvular atrial fibrillation

Investigational / Pivotal TrialActive

Key Facts

Indication
Stroke prevention in patients with non-valvular atrial fibrillation
Phase
Investigational / Pivotal Trial
Status
Active
Company

About Conformal Medical

Conformal Medical is a developer of a novel left atrial appendage occlusion (LAAO) system aimed at reducing stroke risk in AFib patients without the long-term need for anticoagulants. Its CLAAS System is designed to be a same-day, single-operator procedure, potentially improving ease of use and accessibility. The company was acquired by medical device giant W. L. Gore & Associates in early 2026, providing significant resources and commercial expertise to advance the technology through clinical development and future commercialization. The acquisition represents a strategic expansion of Gore's cardiac portfolio into a high-growth adjacency.

View full company profile

Therapeutic Areas